» Articles » PMID: 36040179

SARS-CoV-2 Virus Culture, Genomic and Subgenomic RNA Load, and Rapid Antigen Test in Experimentally Infected Syrian Hamsters

Overview
Journal J Virol
Date 2022 Aug 30
PMID 36040179
Authors
Affiliations
Soon will be listed here.
Abstract

The duration of SARS-CoV-2 genomic RNA shedding is much longer than that of infectious SARS-CoV-2 in most COVID-19 patients. It is very important to determine the relationship between test results and infectivity for efficient isolation, contact tracing, and post-isolation. We characterized the duration of viable SARS-CoV-2, viral genomic and subgenomic RNA (gRNA and sgRNA), and rapid antigen test positivity in nasal washes, oropharyngeal swabs, and feces of experimentally infected Syrian hamsters. The duration of viral genomic RNA shedding is longer than that of viral subgenomic RNA, and far longer than those of rapid antigen test (RAgT) and viral culture positivity. The rapid antigen test results were strongly correlated with the viral culture results. The trend of subgenomic RNA is similar to that of genomic RNA, and furthermore, the subgenomic RNA load is highly correlated with the genomic RNA load. Our findings highlight the high correlation between rapid antigen test and virus culture results. The rapid antigen test would be an important supplement to real-time reverse transcription-RCR (RT-PCR) in early COVID-19 screening and in shortening the isolation period of COVID-19 patients. Because the subgenomic RNA load can be predicted from the genomic RNA load, measuring sgRNA does not add more benefit to determining infectivity than a threshold determined for gRNA based on viral culture.

Citing Articles

Reverse transcription-quantitative PCR assays for detecting SARS-CoV-2 using subgenomic RNA load.

Cheng Y, Chen C, Liu P, Chen W, Hsu C, Chen C Heliyon. 2025; 11(4):e42503.

PMID: 40034326 PMC: 11874546. DOI: 10.1016/j.heliyon.2025.e42503.


Combined immunization with SARS-CoV-2 spike and SARS-CoV nucleocapsid protects K18-hACE2 mice but increases lung pathology.

Kim J, Kachko A, Selvaraj P, Rotstein D, Stauft C, Rajasagi N NPJ Vaccines. 2025; 10(1):30.

PMID: 39948345 PMC: 11825953. DOI: 10.1038/s41541-025-01085-1.


Mixed lipopeptide-based mucosal vaccine candidate induces cross-variant immunity and protects against SARS-CoV-2 infection in hamsters.

Patel R, Duque D, Bavananthasivam J, Hewitt M, Sandhu J, Kumar R Immunohorizons. 2025; 9(2).

PMID: 39849995 PMC: 11841972. DOI: 10.1093/immhor/vlae011.


Predicting the presence of infectious virus from PCR data: A meta-analysis of SARS-CoV-2 in non-human primates.

Snedden C, Lloyd-Smith J PLoS Pathog. 2024; 20(4):e1012171.

PMID: 38683864 PMC: 11081500. DOI: 10.1371/journal.ppat.1012171.


Real-Time Reverse Transcription Recombinase-Aided Amplification Assay for Rapid Amplification of the Gene of SARS-CoV-2.

Cui H, Tu F, Zhang C, Zhang C, Zhao K, Liu J Int J Mol Sci. 2022; 23(23).

PMID: 36499594 PMC: 9736922. DOI: 10.3390/ijms232315269.

References
1.
Verma R, Kim E, Martinez-Colon G, Jagannathan P, Rustagi A, Parsonnet J . SARS-CoV-2 Subgenomic RNA Kinetics in Longitudinal Clinical Samples. Open Forum Infect Dis. 2021; 8(7):ofab310. PMC: 8291522. DOI: 10.1093/ofid/ofab310. View

2.
Tande A, Swift M, Challener D, Berbari E, Tommaso C, Christopherson D . Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel. Clin Infect Dis. 2022; 75(1):e347-e349. PMC: 9129106. DOI: 10.1093/cid/ciac235. View

3.
Dimcheff D, Valesano A, Rumfelt K, Fitzsimmons W, Blair C, Mirabelli C . Severe Acute Respiratory Syndrome Coronavirus 2 Total and Subgenomic RNA Viral Load in Hospitalized Patients. J Infect Dis. 2021; 224(8):1287-1293. PMC: 8083294. DOI: 10.1093/infdis/jiab215. View

4.
Diaz L, Garcia-Salum T, Fuentes-Lopez E, Reyes D, Ortiz J, Chahuan J . High prevalence of SARS-CoV-2 detection and prolonged viral shedding in stools: A systematic review and cohort study. Gastroenterol Hepatol. 2022; 45(8):593-604. PMC: 8783395. DOI: 10.1016/j.gastrohep.2021.12.009. View

5.
Lind M, Schultes O, Robertson A, Houde A, Cummings D, Ko A . Testing Frequency Matters: An Evaluation of the Diagnostic Performance of a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Rapid Antigen Test in US Correctional Facilities. Clin Infect Dis. 2022; 76(3):e327-e335. PMC: 9214176. DOI: 10.1093/cid/ciac450. View